A Clinical Trial to Evaluate the Efficacy and Safety of Choline Alfoscerate Compared to Placebo in Patients With Degenerative Mild Cognitive Impairment

Clinical trial NCT05041790 · UNKNOWN

Trial details

NCT number: NCT05041790
Sponsor: Chong Kun Dang Pharmaceutical
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

Mild Cognitive Impairment

Start date: 2021-09-30
Primary completion: 2024-11-30
Enrollment: 418

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.